Table 4:
Independent Predictors of the Likelihood of Receiving Inpatient Immediate Postpartum Long Acting Reversible Contraception (IPP LARC) compared to non-LARC methods (excluding sterilization)
| Unadjusted OR (95%CI) | Adjusted OR (95%CI) | |
|---|---|---|
| Age, years | ||
| 18–29 | 1.51(1.43–1.58) | 1.72(1.52–1.96) |
| 30–34 | 0.70(0.67–0.75) | 1.21(1.05–1.40) |
| > 35* | -- | -- |
| Race | ||
| Caucasian* | -- | -- |
| African-American | 3.38(3.23–3.56) | 2.53(2.28–2.80) |
| Hispanic | 1.64(1.55–1.72) | 2.01(1.82–2.23) |
| Asian/Pacific Islander | 0.64(0.56–0.72) | 0.92 (0.74–1.13) |
| Native American | 2.21(1.85–2.66) | 4.01(2.91–5.53) |
| Region | ||
| North | 1.62(1.53–1.70) | 1.80(1.63–2.00) |
| MidWest | 0.51(0.47–0.54) | 0.75(0.65–0.87) |
| West | 0.90(0.85–0.95) | 1.03 (0.92–1.16) |
| South* | -- | -- |
| Hospital Location | ||
| Rural | 0.24(0.21–0.27) | 0.14(0.10–0.20) |
| Urban Non-Teaching | 0.19(0.18–0.21) | 0.32(0.28–0.37) |
| Urban Teaching* | -- | -- |
| Hospital Size | ||
| Large* | -- | -- |
| Medium | 0.80(0.76–0.85) | 0.52(0.47–0.57) |
| Small | 0.43(0.39–0.48) | 0.38(0.33–0.44) |
| Population Density Around Hospital | ||
| Central County* | -- | |
| Fringe County | 0.55(0.52–0.59) | 0.66(0.59–0.74) |
| Large Metro County | 0.87(0.82–0.92) | 0.85(0.77–0.94) |
| Small Metro County | 0.57(0.52–0.63) | 0.60(0.49–0.73) |
| Micropolitan | 0.48(0.43–0.54) | 0.93(0.72–1.19) |
| Median Household Income | ||
| 1st Quartile | 2.03(1.94–2.13) | 1.46(1.29–1.65) |
| 2nd Quartile | 0.89(0.85–0.95) | 1.17 (1.02–1.33) |
| 3rd Quartile | 0.72(0.67–0.76) | 1.17 (1.02–1.33) |
| 4th Quartile * | -- | -- |
| Cesarean | 1.23(1.17–1.29) | 1.20(1.10–1.30) |
| Length of Stay per Day | 1.06(1.05–1.07) | 1.05(1.04–1.06) |
| Pre-Existing Comorbidity | ||
| Alcohol Abuse/Dependence | 1.49(1.23–1.82) | 0.87(0.69–1.11) |
| Drug Abuse /Dependence | 2.67(2.40–2.94) | 1.05(0.85–1.30) |
| Depression | 1.64(1.48–1.81) | 0.89(0.77–1.06) |
| Psychosis | 1.81(1.57–2.09) | 1.00(0.84–1.29) |
| Anemia | 1.74(1.63–1.87) | 1.09(0.96–1.24) |
| Coagulopathy | 1.59(1.41–1.81) | 1.01(0.82–1.27) |
| Heart Failure | 1.13(0.96–1.34) | 0.82(0.68–0.99) |
| Hypothyroidism | 0.96(0.85–1.08) | 0.94(0.80–1.09) |
| Seizure Disorder | 1.40(1.21–1.63) | 0.91(0.75–1.10) |
| Obesity | 1.87(1.74–2.01) | 1.09(0.95–1.27) |
| Chronic Lung Disease | 1.78(1.64–1.91) | 1.09(0.96–1.23) |
| Chronic Hypertension | 1.36(1.27–1.47) | 1.10(0.99–1.22) |
| Pre-gestational Diabetes | 1.38(1.25–1.54) | 0.85(0.67–1.08) |
| Delivery-Related Complications | ||
| Post-partum Hemorrhage | 2.23(2.04–2.44) | 1.81(1.54–2.11) |
| Preclampsia | 1.92(1.81–2.04) | 1.35(1.19–1.50) |
| Eclampsia | 1.54(0.83–2.87 | 0.98(0.32–3.08) |
| Transfusion | 2.32(2.02–2.67) | 1.12(0.87–1.44) |
Patients receiving postpartum tubal ligation were excluded from this analysis
CI = Confidence Interval
OR = Odds Ratio
*=
referent group